AREDYLD syndrome

{{Infobox medical condition (new)

| name = AREDYLD syndrome

| synonyms =

| image = Autosomal recessive - en.svg

| image_size = 140px

| alt =

| caption = AREDYLD syndrome is inherited in an autosomal recessive manner

| pronounce =

| field = Endocrinology

| symptoms =

| complications =

| onset =

| duration =

| types =

| causes =

| risks =

| diagnosis =

| differential =

| prevention =

| treatment =

| medication =

| prognosis =

| frequency =

| deaths =

}}

AREDYLD stands for acral renal ectodermal dysplasia lipoatrophic diabetes. AREDLYD is categorized as a rare disease, meaning it affects fewer than 200,000 people in the American population at any given time.

It was characterized in 1983.{{cite journal | vauthors = Pinheiro M, Freire-Maia N, Chautard-Freire-Maia E, Araujo L, Liberman B | title = AREDYLD: a syndrome combining an acrorenal field defect, ectodermal dysplasia, lipoatrophic diabetes, and other manifestations. | journal = Am J Med Genet | volume = 16 | issue = 1 | pages = 29–33 | year = 1983 | pmid = 6638067 | doi = 10.1002/ajmg.1320160106}} A second case was identified in 1992.{{cite journal | vauthors = Breslau-Siderius E, Toonstra J, Baart J, Koppeschaar H, Maassen J, Beemer F | title = Ectodermal dysplasia, lipoatrophy, diabetes mellitus, and amastia: a second case of the AREDYLD syndrome. | journal = Am J Med Genet | volume = 44 | issue = 3 | pages = 374–7 | year = 1992 | pmid = 1488989 | doi = 10.1002/ajmg.1320440321}}